CHICAGO -- For the first time in a phase III trial, overall survival (OS) in unresectable pancreatic cancer improved ...

Novocure (Nasdaq:NVCR) today announced positive results from the Phase 3 PANOVA-3 trial of its tumor-treating fields (TTFields) therapy.

Actuate Therapeutics has set its sights on getting elraglusib approved for pancreatic cancer after the glycogen synthase ...

In the phase 3 PANOVA-3 trial, patients who underwent tumor-treating fields therapy had extended overall survival vs standard ...

He had been having abdominal pain for the past several weeks, but that night it was excruciating — like a knife plunged deep ...

The novel antibody-drug conjugate EBC-129 has been fast tracked by the FDA for approval in pancreatic ductal adenocarcinoma.

In an interview, Arvind Bussetty, MD, and Arvind Trindade, MD, delved into the rising rates of gastrointestinal cancers among younger patients.

Welcome to The Pharma Letter ’s real-time coverage of the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

Learn the signs of pancreatic cancer including unexplained weight loss, distinctive pain patterns, digestive changes, and ...

Pancreatic adenocarcinoma incidence increased among ... noted health systems need to be equipped with tools like endoscopic ultrasound with pancreas biopsy to manage the increase among younger ...

Individuals over 40 with an FR >30 are offered baseline imaging and then three yearly triplets of annual endoscopic ultrasound (EUS ... on the same side of the family, with pancreatic adenocarcinoma.

Renal cell carcinoma is sometimes discovered when you have a CT scan or an ultrasound for another ... that can be adenocarcinomas include lung, pancreatic, and colorectal types.